CASIMIR C OKORO

Allopathic & Osteopathic Physicians|Internal Medicine RIVERDALE, GA NPI 1508948563

General Payments — all program years on this page

$4,245.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 205
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $479.26 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $479.2622

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $609.6234
2019 $456.9123
2020 $588.2528
2021 $191.8011
2022 $1,186.5951
2023 $732.8836
2024 $479.2622

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086201748 Bayer Healthcare Pharmaceuticals Inc. $21.04 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096595904 Novo Nordisk Inc $29.54 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096602001 Novo Nordisk Inc $15.26 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096676670 Novo Nordisk Inc $16.32 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105414972 AstraZeneca Pharmaceuticals LP $22.25 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105730901 AstraZeneca Pharmaceuticals LP $19.72 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114815551 Exact Sciences Corporation $22.93 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114815556 Exact Sciences Corporation $27.83 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116379972 GlaxoSmithKline, LLC. $21.00 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116504897 GlaxoSmithKline, LLC. $14.81 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117342744 Amgen Inc. $29.47 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117342746 Amgen Inc. $19.50 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039470 Boehringer Ingelheim Pharmaceuticals, Inc. $20.71 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039472 Boehringer Ingelheim Pharmaceuticals, Inc. $23.21 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125102390 Abbott Laboratories $22.36 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131210094 PFIZER INC. $23.17 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131888478 PFIZER INC. $15.75 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131983557 PFIZER INC. $26.61 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136039665 Lilly USA, LLC $13.44 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136088458 Lilly USA, LLC $18.73 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136089086 Lilly USA, LLC $27.73 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153753178 IRONWOOD PHARMACEUTICALS, INC $27.88 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.